By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tarveda Therapeutics (Fomerly Known As Blend Therapeutics) 

134 Coolidge Avenue

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-923-4100 Fax: 617-923-4101


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Tarveda To Present On Lead Intracellular Targeting Pentarin PEN-866 At 2017 American Association Of Pharmaceutical Scientists National Biotechnology Conference 5/1/2017 7:18:12 AM
Tarveda To Present PEN-221 Data In Small Cell Lung Cancer Models At 2017 AACR Annual Meeting 3/28/2017 7:31:22 AM
Tarveda To Present PEN-221 Data In Small Cell Lung Cancer Models At 2017 AACR Annual Meeting 3/27/2017 10:26:19 AM
Massachusetts' Tarveda Secures Another $30 Million to Push Cancer Drugs Into Clinic 2/2/2017 7:50:25 AM
Tarveda Provides Year-End Update And Outlines Milestones For 2017 1/5/2017 11:06:33 AM
Tarveda To Present At North American Neuroendocrine Tumor Society (NANETS) Symposium 9/29/2016 12:37:37 PM
Madrigal Wrangles Cancer Deal Worth $163 Million+ Out of Massachusetts' Tarveda 9/19/2016 5:57:16 AM
Tarveda Therapeutics Spins Out Placon to Pursue Development of Next-Gen Cytotoxic Oncology Drugs 3/23/2016 6:52:51 AM
Tarveda Therapeutics To Present At Cowen and Company 36th Annual Health Care Conference 2/29/2016 11:36:11 AM
Tarveda Therapeutics Appoints Oncology Drug Development Leader Leila Alland, M.D., As Chief Medical Officer 1/27/2016 8:37:54 AM
12
//-->